Archive: 11/08/2015
Insulin degludec plus liraglutide: No hint of added benefit in type 2 diabetes
The fixed-ratio combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since September 2014 for adults with type 2 diabetes mellitus. It is given as an injection in addition ...
Aug 11, 2015
Vortioxetine in depression: No hint of added benefit
Vortioxetine (trade name: Brintellix) has been approved since December 2013 for the treatment of depression in adults, but did not become actually available before May 2015. The German Institute for Quality and Efficiency ...
Aug 11, 2015
Can America cope with a resurgence of tropical disease?
One rainy Friday morning in March 2015, Dr Laila Woc-Colburn saw two patients with neurocysticercosis (a parasitic infection of the brain) and one with Chagas disease, which is transmitted by insects nicknamed 'kissing bugs'. ...
Aug 11, 2015